Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

ABMD

ABIOMED (ABMD)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABMD
DataOraFonteTitoloSimboloCompagnia
06/01/202312:40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ABMDABIOMED Inc
03/01/202314:31Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ABMDABIOMED Inc
27/12/202223:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABMDABIOMED Inc
22/12/202222:47Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ABMDABIOMED Inc
22/12/202222:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABMDABIOMED Inc
22/12/202215:15Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ABMDABIOMED Inc
22/12/202215:01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ABMDABIOMED Inc
22/12/202214:51Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ABMDABIOMED Inc
21/12/202223:33Business WireLa FDA approuve la pompe cardiaque Impella ECP et les premiers patients sont recrutés dans un essai clinique pivotNASDAQ:ABMDABIOMED Inc
21/12/202223:13Business WireImpella ECP-Herzpumpe erhält FDA-Zulassung – erste Patienten in zulassungsrelevante klinische Studie aufgenommenNASDAQ:ABMDABIOMED Inc
21/12/202215:00Business WireFDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical TrialNASDAQ:ABMDABIOMED Inc
20/12/202200:35PR Newswire (US)Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400NASDAQ:ABMDABIOMED Inc
06/12/202209:13Business WireErste Patienten weltweit mit Impella RP Flex mit SmartAssist behandeltNASDAQ:ABMDABIOMED Inc
06/12/202204:20Business WireImpella RP Flex with SmartAssistによる治療を世界で初めて実施NASDAQ:ABMDABIOMED Inc
05/12/202222:44Business WirePremiers patients au monde traités par Impella RP Flex avec SmartAssistNASDAQ:ABMDABIOMED Inc
05/12/202214:03Business WireFirst Patients in the World Treated with Impella RP Flex with SmartAssistNASDAQ:ABMDABIOMED Inc
15/11/202212:51Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:ABMDABIOMED Inc
15/11/202212:51Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:ABMDABIOMED Inc
14/11/202223:34Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ABMDABIOMED Inc
02/11/202201:13Business WireImpella RP Flex with SmartAssistが右心不全の治療としてFDA認可を取得NASDAQ:ABMDABIOMED Inc
01/11/202222:27Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:ABMDABIOMED Inc
01/11/202219:19Dow Jones NewsTrending: Johnson & Johnson to Buy AbiomedNASDAQ:ABMDABIOMED Inc
01/11/202213:45TipRanksJ&J Is Acquiring Abiomed for $16.6BNASDAQ:ABMDABIOMED Inc
01/11/202213:15TipRanksBTIG Remains a Hold on Abiomed (ABMD)NASDAQ:ABMDABIOMED Inc
01/11/202212:00Business WireAbiomed Announces Second Quarter Revenue of $266 Million, up 11% in Constant Currency*, up 7% on a Reported Basis Year Over YearNASDAQ:ABMDABIOMED Inc
01/11/202211:30Business WireJohnson & Johnson to Acquire AbiomedNASDAQ:ABMDABIOMED Inc
31/10/202216:37Business WireImpella RP Flex mit SmartAssist erhält FDA-Zulassung für die Behandlung von RechtsherzinsuffizienzNASDAQ:ABMDABIOMED Inc
31/10/202213:11Business WireImpella RP Flex avec SmartAssist reçoit une approbation de la FDA pour traiter l'insuffisance ventriculaire droiteNASDAQ:ABMDABIOMED Inc
31/10/202213:02Business WireImpella RP Flex with SmartAssist Receives FDA Approval to Treat Right Heart FailureNASDAQ:ABMDABIOMED Inc
26/10/202214:02Business Wire Abiomed Creates Patient Assistance Program to Address Disparities in HealthcareNASDAQ:ABMDABIOMED Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABMD
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network